Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists
Atherosclerosis is a chronic inflammatory vascular disease. Toll-like receptors (TLRs) are major initiators of inflammation. TLR2 promotes atherosclerosis in LDL receptor (LDLr)-deficient mice fed a high-fat diet (HFD). TLR2 forms heterodimers with TLR1 or TLR6 to enable inflammatory responses in th...
Main Authors: | Linda K. Curtiss, Audrey S. Black, David J. Bonnet, Peter S. Tobias |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-10-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S002222752043189X |
Similar Items
-
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
by: Amani E. Khalifa, PhD, et al.
Published: (2021-01-01) -
Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2021-09-01) -
The Effects of Polyhexamethylene Biguanide (PHMB) and TLR Agonists Alone or as Polyplex Nanoparticles against <em>Leishmania infantum</em> Promastigotes and Amastigotes
by: Pamela Martínez-Orellana, et al.
Published: (2020-11-01) -
Physicochemical characterization of biological and synthetic forms of two lipid A-based TLR4 agonists
by: Gang Hu, et al.
Published: (2023-07-01) -
Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
by: Fernando Torres Andón, et al.
Published: (2022-07-01)